Camlin Fine Sciences' Q1 FY 2026-27 Quarterly Results

Result Summary

• Camlin Fine Sciences Ltd reported a 16.2% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 20.6%.
• Its expenses for the quarter were up by 21.5% QoQ and 24.4% YoY.
• The net profit decreased 139.0% QoQ and increased 214.9% YoY.
• The earnings per share (EPS) of Camlin Fine Sciences Ltd declined at 1.65 during Q1 FY 2026-27.

Financial Statments for Q1 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Camlin Fine Sciences Ltd is a company operating in the chemical industry, specializing in the manufacturing and distribution of fine chemicals, including antioxidants, aroma chemicals, and performance chemicals. These products are used across various sectors, such as food, feed, petrochemicals, and pharmaceuticals, to enhance product longevity and quality. The company has positioned itself as a key player in providing solutions that enhance the safety and stability of end products used by consumers. While specific recent developments are not provided in the data, the company’s focus remains on expanding its product offerings and geographical reach to meet global demand.

Revenue

During Q1FY27, Camlin Fine Sciences Ltd reported a total income of ₹521.22 crores, marking an increase from ₹448.72 crores in Q4FY26 and ₹432.12 crores in Q1FY26. This represents a quarter-over-quarter (QoQ) increase of 16.2% and a year-over-year (YoY) growth of 20.6%. The revenue growth can be attributed to an increase in sales volume, enhanced product offerings, or expansion into new markets. The consistent rise in income over both quarters and the year suggest a positive trajectory in capturing market share or improving pricing strategies.

Profitability

The profitability metrics for Camlin Fine Sciences Ltd indicate a challenging quarter. The company recorded a loss before tax of ₹33.66 crores in Q1FY27, a significant increase from losses of ₹6.65 crores in Q4FY26 and ₹5.15 crores in Q1FY26. This reflects a QoQ increase in losses by 406.2% and a YoY increase by 553.6%. Despite the rise in total income, the profit after tax (PAT) for Q1FY27 was a loss of ₹33.63 crores, compared to a profit of ₹86.28 crores in Q4FY26 and a loss of ₹10.68 crores in Q1FY26. Earnings per share (EPS) also decreased to ₹-1.65 in Q1FY27 from ₹4.54 in Q4FY26, highlighting the company's challenges in maintaining profitability.

Operating Metrics

The total expenses for Camlin Fine Sciences Ltd in Q1FY27 were ₹543.76 crores, up from ₹447.42 crores in Q4FY26 and ₹437.27 crores in Q1FY26, indicating a QoQ increase of 21.5% and a YoY increase of 24.4%. This rise in expenses could be attributed to increased raw material costs, operational expansion, or inflationary pressures. The tax expense for Q1FY27 was marginally lower at ₹-0.46 crores compared to ₹-6.24 crores in Q4FY26, but significantly higher than the ₹-0.01 crores in Q1FY26. The variance in tax expenses suggests shifts in the company's tax obligations or adjustments. The noted increase in total expenses and tax components have contributed to the overall financial outcomes for the quarter.